Pharmaceuticals, Biotechnology and Life Sciences
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE:AMRX) today announced that members of management will participate in a fireside chat at the…
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE:AMRX) today announced that members of management will participate in a fireside chat at the…
-Multi-year collaboration leveraging Kymera’s proprietary targeted protein degradation platform to develop novel medicines- -Kymera to receive $70 million upfront, including…
New Company and Collaboration To Develop Novel Therapeutics Including Vonoprazan for the Treatment of Acid-Related Disorders in North America and…
Mavorixafor selected for LLS’s Therapy Acceleration Program® (TAP) CAMBRIDGE, Mass. & RYE BROOK, N.Y.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq:XFOR), a clinical-stage…
Alliance will Utilize Technology from Applied DNA Sciences in ETCH biotrace™ to Secure Supply Chains STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA…
PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today…
AUSTIN, Texas–(BUSINESS WIRE)–Elligo Health Research, an integrated research organization (IRO), announces the launch of its innovative IntElligo Research Stack™ clinical…
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at the RBC Capital Markets 2019 Global Healthcare…
COOKEVILLE, Tenn.–(BUSINESS WIRE)–Aphena Pharma Solutions Inc. today announced that it has approved $7 million for company-wide expansion for future growth…